|
1
|
Neeper M, Schmidt AM, Brett J, Yan SD,
Wang F, Pan YC, Elliston K, Stern D and Shaw A: Cloning and
expression of a cell surface receptor for advanced glycosylation
end products of proteins. J Biol Chem. 267:14998–15004.
1992.PubMed/NCBI
|
|
2
|
Hudson BI, Carter AM, Harja E, Kalea AZ,
Arriero M, Yang H, Grant PJ and Schmidt AM: Identification,
classification, and expression of RAGE gene splice variants. FASEB
J. 22:1572–1580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
López-Díez R, Rastrojo A, Villate O and
Aguado B: Complex tissue-specific patterns and distribution of
multiple RAGE splice variants in different mammals. Genome Biol
Evol. 5:2420–2435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yonekura H, Yamamoto Y, Sakurai S, Petrova
RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, et
al: Novel splice variants of the receptor for advanced glycation
end-products expressed in human vascular endothelial cells and
pericytes, and their putative roles in diabetes-induced vascular
injury. Biochem J. 370:1097–1109. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maillard-Lefebvre H, Boulanger E, Daroux
M, Gaxatte C, Hudson BI and Lambert M: Soluble receptor for
advanced glycation end products: A new biomarker in diagnosis and
prognosis of chronic inflammatory diseases. Rheumatology (Oxford).
48:1190–1196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raucci A, Cugusi S, Antonelli A, Barabino
SM, Monti L, Bierhaus A, Reiss K, Saftig P and Bianchi ME: A
soluble form of the receptor for advanced glycation endproducts
(RAGE) is produced by proteolytic cleavage of the membrane-bound
form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
FASEB J. 22:3716–3727. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang L, Bukulin M, Kojro E, Roth A, Metz
VV, Fahrenholz F, Nawroth PP, Bierhaus A and Postina R: Receptor
for advanced glycation end products is subjected to protein
ectodomain shedding by metalloproteinases. J Biol Chem.
283:35507–35516. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y,
Shen X, Liang Z, Cai S and Zou F: High mobility group protein B1
(HMGB1) in asthma: Comparison of patients with chronic obstructive
pulmonary disease and healthy controls. Mol Med. 17:807–815. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ozseker F, Buyukozturk S, Depboylu B,
Yilmazbayhan D, Karayigit E, Gelincik A, Genc S, Colakoglu B, Dal M
and Issever H: Serum amyloid A (SAA) in induced sputum of
asthmatics: A new look to an old marker. Int Immunopharmacol.
6:1569–1576. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Z, Yan WX, Cai H, Tedla N, Armishaw
C, Di Girolamo N, Wang HW, Hampartzoumian T, Simpson JL, Gibson PG,
et al: S100A12 provokes mast cell activation: A potential
amplification pathway in asthma and innate immunity. J Allergy Clin
Immunol. 119:106–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Watanabe T, Asai K, Fujimoto H, Tanaka H,
Kanazawa H and Hirata K: Increased levels of HMGB-1 and endogenous
secretory RAGE in induced sputum from asthmatic patients. Respir
Med. 105:519–525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buckley ST and Ehrhardt C: The receptor
for advanced glycation end products (RAGE) and the lung. J Biomed
Biotechnol. 2010:9171082010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Demling N, Ehrhardt C, Kasper M, Laue M,
Knels L and Rieber EP: Promotion of cell adherence and spreading: A
novel function of RAGE, the highly selective differentiation marker
of human alveolar epithelial type I cells. Cell Tissue Res.
323:475–488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Milutinovic PS, Alcorn JF, Englert JM,
Crum LT and Oury TD: The receptor for advanced glycation end
products is a central mediator of asthma pathogenesis. Am J Pathol.
181:1215–1225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sukkar MB, Ullah MA, Gan WJ, Wark PA,
Chung KF, Hughes JM, Armour CL and Phipps S: RAGE: A new frontier
in chronic airways disease. Br J Pharmacol. 167:1161–1176. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ,
Chow WS, Stern D and Schmidt AM: Suppression of accelerated
diabetic atherosclerosis by the soluble receptor for advanced
glycation endproducts. Nat Med. 4:1025–1031. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vazzana N, Santilli F, Cuccurullo C and
Davì G: Soluble forms of RAGE in internal medicine. Intern Emerg
Med. 4:389–401. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nin JW, Jorsal A, Ferreira I, Schalkwijk
CG, Prins MH, Parving H, Tarnow L, Rossing P and Stehouwer CD:
Higher plasma soluble receptor for advanced glycation end products
(sRAGE) levels are associated with incident cardiovascular disease
and all-cause mortality in type 1 diabetes: A 12-year follow-up
study. Diabetes. 59:2027–2032. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thomas MC, Söderlund J, Lehto M, Mäkinen
VP, Moran JL, Cooper ME, Forsblo C and Groop PH; FinnDiane Study
Group, : Soluble receptor for AGE (RAGE) is a novel independent
predictor of all-cause and cardiovascular mortality in type 1
diabetes. Diabetologia. 54:2669–2677. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sukkar MB, Wood LG, Tooze M, Simpson JL,
McDonald VM, Gibson PG and Wark PA: Soluble RAGE is deficient in
neutrophilic asthma and COPD. Eur Respir J. 39:721–729. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng DT, Kim DK, Cockayne DA, Belousov A,
Bitter H, Cho MH, Duvoix A, Edwards LD, Lomas DA, Miller BE, et al:
Systemic soluble receptor for advanced glycation endproducts is a
biomarker of emphysema and associated with AGER genetic variants in
patients with chronic obstructive pulmonary disease. Am J Respir
Crit Care Med. 188:948–957. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miniati M, Monti S, Basta G, Cocci F,
Fornai E and Bottai M: Soluble receptor for advanced glycation end
products in COPD: Relationship with emphysema and chronic cor
pulmonale: A case-control study. Respir Res. 12:372011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hoonhorst SJ, Lo Tam Loi AT, Pouwels SD,
Faiz A, Telenga E, Van den Berge M, Koenderman L, Lammers JW,
Boezen HM, van Oosterhout M, et al: Advanced glycation endproducts
and their receptor in different body compartments in COPD. Respir
Res. 17:462016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iwamoto H, Gao J, Pulkkinen V, Toljamo T,
Nieminen P and Mazur W: Soluble receptor for advanced glycation
end-products and progression of airway disease. BMC Pulm Med.
14:682014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smith DJ, Yerkovich ST, Towers MA, Carroll
ML, Thomas R and Upham JW: Reduced soluble receptor for advanced
glycation end-products in COPD. Eur Respir J. 37:516–522. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hudson BI, Stickland MH and Grant PJ:
Identification of polymorphisms in the receptor for advanced
glycation end products (RAGE) gene: Prevalence in type 2 diabetes
and ethnic groups. Diabetes. 47:1155–1157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miller S, Henry AP, Hodge E, Kheirallah
AK, Billington CK, Rimington TL, Bhaker SK, Obeidat M, Melén E,
Merid SK, et al: The Ser82 RAGE variant affects lung function and
serum RAGE in smokers and sRAGE production in vitro. PLoS One.
11:e1640412016. View Article : Google Scholar
|
|
28
|
Gaens KH, Ferreira I, van der Kallen CJ,
van Greevenbroek MM, Blaak EE, Feskens EJ, Dekker JM, Nijpels G,
Heine RJ, 't Hart LM, et al: Association of polymorphism in the
receptor for advanced glycation end products (RAGE) gene with
circulating RAGE levels. J Clin Endocrinol Metab. 94:5174–5180.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hancock DB, Eijgelsheim M, Wilk JB, Gharib
SA, Loehr LR, Marciante KD, Franceschini N, van Durme YM, Chen TH,
Barr RG, et al: Meta-analyses of genome-wide association studies
identify multiple loci associated with pulmonary function. Nat
Genet. 42:45–52. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Repapi E, Sayers I, Wain LV, Burton PR,
Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, et al:
Genome-wide association study identifies five loci associated with
lung function. Nat Genet. 42:36–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou Y, Jiang YQ, Wang WX, Zhou ZX, Wang
YG, Yang L and Ji YL: HMGB1 and RAGE levels in induced sputum
correlate with asthma severity and neutrophil percentage. Hum
Immunol. 73:1171–1174. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bateman ED, Hurd SS, Barnes PJ, Bousquet
J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen
SE, et al: Global strategy for asthma management and prevention:
GINA executive summary. Eur Respir J. 31:143–178. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
El-Seify MY, Fouda EM and Nabih ES: Serum
level of soluble receptor for advanced glycation end products in
asthmatic children and its correlation to severity and pulmonary
functions. Clin Lab. 60:957–962. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu TL, Tsai CC, Wang YY, Ho KY, Wu YM,
Hung HC and Lin YC: The association between the RAGE G82S
polymorphism, sRAGE and chronic periodontitis in Taiwanese
individuals with and without diabetes. J Periodontal Res.
50:881–889. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hirota T, Takahashi A, Kubo M, Tsunoda T,
Tomita K, Doi S, Fujita K, Miyatake A, Enomoto T, Miyagawa T, et
al: Genome-wide association study identifies three new
susceptibility loci for adult asthma in the Japanese population.
Nat Genet. 43:893–896. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Iwamoto H, Gao J, Koskela J, Kinnula V,
Kobayashi H, Laitinen T and Mazur W: Differences in plasma and
sputum biomarkers between COPD and COPD-asthma overlap. Eur Respir
J. 43:421–429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bozinovski S, Hutchinson A, Thompson M,
Macgregor L, Black J, Giannakis E, Karlsson AS, Silvestrini R,
Smallwood D, Vlahos R, et al: Serum amyloid a is a biomarker of
acute exacerbations of chronic obstructive pulmonary disease. Am J
Respir Crit Care Med. 177:269–278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ferhani N, Letuve S, Kozhich A, Thibaudeau
O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle
AJ, et al: Expression of high-mobility group box 1 and of receptor
for advanced glycation end products in chronic obstructive
pulmonary disease. Am J Respir Crit Care Med. 181:917–927. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yerkovich ST, Chang AB, Carroll ML, Petsky
HL, Scrivener G and Upham JW: Soluble receptor for advanced
glycation end products (sRAGE) is present at high concentrations in
the lungs of children and varies with age and the pattern of lung
inflammation. Respirology. 17:841–846. 2012. View Article : Google Scholar : PubMed/NCBI
|
